Global Cell Therapy Technologies Market Worth $7.8 Billion by 2027: Thermo Fisher Scientific, Merck, Danaher, BD, Lonza Group, and Sartorius Dominate

DUBLIN, Aug. 23, 2023 /PRNewswire/ -- The "Cell Therapy Technologies Market by Product (Media, Sera & Reagents, Cell Culture Vessels, Single-Use Equipment), Process (Cell Processing, Preservation), Cell type (T-Cells, Stem cells), End User (Biopharma, CROs, CMOs), Region - Global Forecast to 2028" report has been added to  ResearchAndMarkets.com's offering.

The global landscape of cell therapy technologies is experiencing a significant trajectory of growth, with a projection to reach USD 7.8 billion by 2028 from its 2023 valuation of USD 4.2 billion. This remarkable journey is guided by a robust CAGR of 13.3%. Several compelling factors are contributing to this surge, including increased government investments in cell-based research, a rising prevalence of chronic and infectious diseases, a multitude of oncology-related cell therapy clinical trials, and a growing trend towards GMP certification for cell therapy production facilities.

Market Dynamics and Key Factors

• Government Investments in Cell-Based Research: Heightened support from governments for cell-based research is a pivotal driver, fostering advancements in cell therapies and their applications.
• Incidence of Chronic and Infectious Ailments: The increasing burden of chronic and infectious diseases has accelerated the exploration of cell therapy solutions, driving market growth.
• Oncology-Related Clinical Trials: A substantial number of clinical trials focusing on oncology-related cell therapies are propelling advancements and growth in the market.
• GMP Certification: The escalating trend in GMP (Good Manufacturing Practice) certification for cell therapy production facilities ensures high-quality products, further promoting market expansion.

Segment Insights

Process Segment Dominance: Among various segments, the process segment, encompassing cell processing, preservation, distribution & handling, and quality control, held the dominant share in 2022. Advancements in cell processing techniques are expected to positively impact market growth.

Application in Biopharmaceutical and Biotechnology Companies: The biopharmaceutical and biotechnology companies segment accounted for the largest share in the application segment in 2022. This dominance is attributed to the emphasis on increasing the number of cell therapy manufacturing facilities by key players and rising investments in research activities.

Regional Outlook

• Asia Pacific Growth: The Asia Pacific region is anticipated to experience significant growth, driven by increasing government investments in cell-based research. Countries like China, India, and Japan are demanding cell therapy instruments and products due to research funding for vaccine development and evolving disease profiles.
• Chronic Diseases and Geriatric Population: Factors such as the rising incidence of chronic and infectious diseases, an aging population, and government initiatives for healthcare infrastructure improvements contribute to the positive impact on market growth in the Asia Pacific region.

Leading Market Players

The report provides an in-depth competitive evaluation of key market players, including Thermo Fisher Scientific, Inc., Merck KGaA, Danaher Corporation, Becton, Dickinson, and Company, Lonza Group, and Sartorius AG. These influential contenders are driving the evolution of the cell therapy technologies industry with distinctive corporate profiles, recent advancements, and pivotal market strategies.

In Conclusion

The global cell therapy technologies market is experiencing remarkable growth, fueled by diverse factors such as government investments, disease prevalence, clinical trials, and quality certification trends. The dominance of certain segments and regions, along with the contributions of key market players, further underline the significant growth potential in the coming years.

Market Dynamics

• Drivers
• Increasing Government Investments in Cell-based Research
• Rising Incidence of Chronic and Infectious Diseases
• Large Number of Oncology-related Cell Therapy Clinical Trials
• Increasing GMP Certifications for Cell Therapy Production Facilities
• Restraints
• High Cost of Cell-based Research and Low Success Rate
• Opportunities
• Emergence of IPSCs as Alternatives to ESCs
• Increased Focus on Personalized Medicine
• Increasing Partnerships for the Development of Cell Therapies
• Emerging Asian Markets
• Challenges
• Survival of Small Players and New Entrants

Premium Insights

• Increasing Government Investment in Cell-based Research to Boost Adoption of Cell Therapy Technologies
• T Cells Accounted for Largest Market Share in 2022
• Media, Sera, and Reagents Segment to Dominate Market in 2028
• Biopharmaceutical & Biotechnology Companies Dominated Market in 2022
• Asia-Pacific Countries to Register Highest Growth from 2023 to 2028

Other Key Insights

• Trends/Disruptions Impacting Customers' Businesses
• Indicative Pricing Model Analysis
• Technology Analysis
• Value Chain Analysis
• Supply Chain Analysis
• Ecosystem Analysis of Cell Therapy Technologies Market
• Key Conferences and Events in 2022-2023
• Regulatory Analysis
• Porter's Five Forces Analysis
• Patent Analysis
• Key Stakeholders and Buying Criteria

Companies Profiled

• Key Market Players
• Thermo Fisher Scientific, Inc.
• Merck KGaA
• Danaher Corporation
• Lonza Group
• Sartorius AG
• Terumo BCT, Inc.
• Becton Dickinson and Company
• Fresenius SE & Co. KGaA
• Avantor, Inc.
• Bio-Techne
• Corning Incorporated
• Fujifilm Irvine Scientific
• Maxcyte, Inc.
• Other Players
• Werum IT Solutions
• RoosterBio, Inc.
• Sirion Biotech
• Trakcel
• L7 Informatics, Inc.
• Miltenyi Biotec B.V. & Co. KG
• Stemcell Technologies
• GPI Iberia (Formerly Hemasoft)
• MAK-System
• Organabio
• iXCells Biotechnologies
• Wilson Wolf

Key Topics Covered

1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Cell Therapy Technologies Market, by Product
7 Cell Therapy Technologies Market, by Process
8 Cell Therapy Technologies Market, by Cell Type
9 Cell Therapy Technologies Market, by End-user
10 Cell Therapy Technologies Market, by Region
11 Competitive Landscape
12 Company Profiles
13 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/9woetk

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets